Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1636

    1.

    In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations.

    De Vecchi E, Nicola L, Larosa M, Drago L.

    BMC Microbiol. 2008 Jan 29;8:23.PMID: 18230154 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.

    Kosowska K, Credito K, Pankuch GA, Hoellman D, Lin G, Clark C, Dewasse B, McGhee P, Jacobs MR, Appelbaum PC.

    Antimicrob Agents Chemother. 2004 Nov;48(11):4113-9.PMID: 15504829 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.

    Drago L, De Vecchi E, Nicola L, Colombo A, Gismondo MR.

    J Antimicrob Chemother. 2004 Aug;54(2):542-5. Epub 2004 Jun 23.PMID: 15215227 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Kinetic bactericidal activity of telithromycin, azithromycin and clarithromycin against respiratory pathogens.

    Drago L, De Vecchi E, Nicola L, Legnani D, Gismondo MR.

    APMIS. 2005 Oct;113(10):655-63.PMID: 16309423 [PubMed - indexed for MEDLINE]Related articles

    5.

    Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.

    Bogdanovich T, Clark C, Ednie L, Lin G, Smith K, Shapiro S, Appelbaum PC.

    Antimicrob Agents Chemother. 2006 Jun;50(6):2050-7.PMID: 16723565 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.

    Walsh F, Carnegy F, Willcock J, Amyes S.

    J Antimicrob Chemother. 2004 May;53(5):793-6. Epub 2004 Mar 31.PMID: 15056640 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.

    Delmée M, Carpentier M, Glupczynski Y, Gordts B, Magerman K, Simon A, Surmont I, Van de Vyvere M, Van Landuyt H, Van Nimmen L, Van Noyen R.

    Acta Clin Belg. 1996;51(4):237-43.PMID: 8858889 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.

    Bogdanovich T, Bozdogan B, Appelbaum PC.

    Antimicrob Agents Chemother. 2006 Mar;50(3):893-8.PMID: 16495248 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.

    Zhanel GG, Palatnick L, Nichol KA, Low DE, Hoban DJ; CROSS Study Group.

    Antimicrob Agents Chemother. 2003 Jun;47(6):1875-81.PMID: 12760861 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    In vitro activity of telithromycin against respiratory tract pathogens in comparison with other antimicrobial agents.

    Ling TK, Lee CC.

    Chemotherapy. 2005 Jul;51(4):182-5. Epub 2005 Jun 23.PMID: 15980628 [PubMed - indexed for MEDLINE]Related articles

    14.

    Human serum activity of telithromycin, azithromycin and amoxicillin/clavulanate against common aerobic and anaerobic respiratory pathogens.

    Stein GE, Schooley S, Tyrrell KL, Citron DM, Goldstein EJ.

    Int J Antimicrob Agents. 2007 Jan;29(1):39-43.PMID: 17189093 [PubMed - indexed for MEDLINE]Related articles

    16.

    Impact of carbon dioxide on the susceptibility of key respiratory tract pathogens to telithromycin and azithromycin.

    Bouchillon SK, Johnson JL, Hoban DJ, Stevens TM, Johnson BM.

    J Antimicrob Chemother. 2005 Jul;56(1):224-7. Epub 2005 May 12.PMID: 15890718 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance.

    Burgess DS, Hastings RW, Horan JL.

    Ann Pharmacother. 1999 Dec;33(12):1262-5.PMID: 10630825 [PubMed - indexed for MEDLINE]Related articles

    18.

    Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations.

    Zhanel GG, Johanson C, Hisanaga T, Mendoza C, Laing N, Noreddin A, Wierzbowski A, Hoban DJ.

    J Antimicrob Chemother. 2004 Dec;54(6):1072-7. Epub 2004 Nov 5.PMID: 15531596 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    [Activity of telithromycin and other oral antibiotics against respiratory tract pathogens with acquired mechanisms of resistance]

    Gómez-Garcés JL, Alós JI, Hernáiz C, Gómez C.

    Enferm Infecc Microbiol Clin. 2004 Jun-Jul;22(6):323-7. Spanish. PMID: 15228898 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination